Abstract
Postinduction intensification therapy (PII) has been key to success in the treatment of many types of childhood cancer and has led to an increase in cure rates during the past 3 decades. This Practice Point commentary discusses the recent findings of the Children's Cancer Group CCG-1961 study, which enrolled 2,078 children and adolescents with acute lymphoblastic leukemia. Patients with rapid marrow response to induction therapy were randomly allocated in a 2 × 2 factorial trial to receive either longer or increased intensity PII. A clear advantage—9% improved event-free survival and 6% improved overall survival at 5 years—was shown for more-intensive but not for longer PII; however, a high incidence of osteonecrosis and an increased rate of infections were observed in rapid early responders. This commentary emphasizes the need to balance the beneficial effects of PII in terms of disease control against the possibility of potentially debilitating late adverse sequelae.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Henze G et al. (1981) The BFM 76/79 acute lymphoblastic leukemia therapy study (German). Klin Pädiat 193: 145–154
Nachman JB et al. (1998) Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 338: 1663–1671
Seibel NL et al. (2008) Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 111: 2548–2555
Reiter A et al. (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL-BFM 86. Blood 84: 3122–3133
Kamps WA et al. (2000) Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991. Leukemia 14: 2240–2246
Karachunskiy A et al. (2008) Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia 22: 1144–1153
Te Poele EM et al. (2007) Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high? Eur J Cancer 43: 2532–2536
Mattano LA Jr et al. (2000) Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 18: 3262–3272
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Henze, G. Early postinduction intensification therapy is essential in childhood acute lymphoblastic leukemia. Nat Rev Clin Oncol 5, 502–503 (2008). https://doi.org/10.1038/ncponc1184
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc1184